UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:January 29,
Soligenix (NASDAQ:SNGX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Soligenix Charts.
Soligenix (NASDAQ:SNGX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Soligenix Charts.

Soligenix, Inc. News

Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South Africa
Thursday 25 April 2024 (1 week ago) • PR Newswire (US)
Soligenix Announces Pricing of $4.75 Million Public Offering
Thursday 18 April 2024 (2 weeks ago) • PR Newswire (US)
FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection
Monday 15 April 2024 (3 weeks ago) • PR Newswire (US)
FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection
Thursday 11 April 2024 (3 weeks ago) • PR Newswire (US)
Soligenix Announces Agreement on the Design of a Second Confirmatory Placebo-Controlled Trial for HyBryte™ With the European Medicines Agency
Wednesday 3 April 2024 (4 weeks ago) • PR Newswire (US)
Soligenix Announces Recent Accomplishments and Year End 2023 Financial Results
Friday 15 March 2024 (2 months ago) • PR Newswire (US)
Soligenix Announces Formation of Behçet's Disease Medical Advisory Board
Thursday 8 February 2024 (3 months ago) • PR Newswire (US)
Soligenix to Present at The Microcap Conference
Thursday 25 January 2024 (3 months ago) • PR Newswire (US)
FDA Grants Soligenix "Fast Track" Designation for Dusquetide in the Treatment of Oral Lesions of Behçet's Disease
Monday 8 January 2024 (4 months ago) • PR Newswire (US)
Soligenix Announces Top-line Results of the Phase 2a Study of SGX302 (Synthetic Hypericin) in Patients with Mild-to-Moderate Psoriasis
Thursday 4 January 2024 (4 months ago) • PR Newswire (US)
Soligenix Announces Publication Demonstrating Complete Protection Against Filovirus Disease in Nonhuman Primate Models of Ebola and Marburg Viruses
Tuesday 2 January 2024 (4 months ago) • PR Newswire (US)
Form 8-K - Current report
Friday 22 December 2023 (4 months ago) • Edgar (US Regulatory)

More Soligenix, Inc. News Articles